Abstract The utilization of redox mediators (RMs) in lithium-oxygen batteries (LOBs) have underscored their utility in addressing the challenge of the elevated overpotential during the charging process. Nonetheless, the generation of highly electrophilic singlet oxygen (¹O₂) throughout the battery cycles leads to adverse reactions with RMs, thereby impeding their effectiveness. In the quest for enhanced RM durability, this study unveils a novel RM, 7,7'-bi-7-azabicyclo[2.2.1]heptane (BAC), incorporating N–N interconnected aza-bicycles, and assesses its efficacy and robustness relative to those of other N–N non-bicyclic RMs. Unlike non-bicyclic RMs, which exhibit diminished O₂ evolution after exposure to ¹O₂, BAC maintains consistent O₂ profiles during charging, indicating its superior ¹O₂ resistance and steady redox-catalyst performance in LOBs. Theoretical analyses align with the experimental findings that the bicyclic structural design of BAC confers a superior ability to resist oxidative degradation through cleavage of the C–H bonds adjacent to nitrogen atoms.
No takes yet. Share an insight, caveat, or question.
Kwak et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: